产地国家：美国 处方药：是 所属类别： 90毫克/毫升, 180毫克/2毫升/瓶 包装规格： 90毫克/毫升, 180毫克/2毫升/瓶 计价单位：瓶 生产厂家英文名：TEVA 原产地英文商品名：TREANDA 90mg/ ML, 180mg 2ML/vial 原产地英文药品名：Bendamustine HCL 中文参考商品译名：TREANDA 90毫克/毫升, 180毫克/2毫升/瓶 中文参考药品译名：苯达莫司汀

简介：

部份中文苯达莫司汀处方资料（仅供参考）最近，美国FDA于2008年3月21日批准Cephalon公司的盐酸苯达莫司汀（bendamustine，Treanda）用于慢性淋巴细胞性白血病（CLL）。CLL是1种恶性的淋巴细胞克隆性增殖性疾病，多见于老年人，平均发病年龄70岁，且男性多于女性。据美国癌症学会预计，2008年美国将有15000例CLL新发病例。分析师预计本品年销售峰值在3～5亿美元。此外，本品另一适应证－非霍奇金淋巴瘤目前正等待FDA批准。盐酸苯达莫司汀（Bendamustine　Hydrochloride）是一种双功能基烷化剂，具有抗肿瘤和杀细胞作用。本品的抗肿瘤和杀细胞作用主要归功于DNA单链和双联通过烷化作用交联，这打乱了DNA的功能和DNA的合成，也会使DNA和蛋白之间，以及蛋白和蛋白之间产生交联，从而发挥抗肿瘤作用。本品作为单用或联合化疗，对何杰金氏淋巴瘤和非何杰金氏淋巴瘤的治疗反应率分别为61％～97％和41％～48％。本项目主要　应用于单独或与其它抗肿瘤药物联合用药来治疗下列恶性肿瘤：何杰金病；非何杰金淋巴瘤；浆细胞瘤（多发性骨髓瘤）；慢性淋巴细胞白血病（CLL）；乳腺癌。本品用于何杰金病、非何杰金淋巴瘤、多发性骨髓瘤、CLL和乳腺癌。其剂量血癌为50～60mg／m²／d，3～5天或每3～4周为100～120mg／m²；实体瘤每4周为120～150mg／m²，每日1次，30～60min静脉滴注。盐酸苯达莫司汀作为单用或联合化疗，对何杰金病和非何杰金淋巴瘤的治疗反应率分别为61％～97％和41％～48　％。对多发性骨髓瘤病人，苯达莫司汀／泼尼松治疗的完全反应率较高（32％），美法仑／泼尼松疗法反应更持久。在环磷酰胺、长春新碱、泼尼松治疗方案中，苯达莫司汀取代环磷酰胺，对发展中低度毒性非何杰金淋巴瘤有相似的反应率。在环磷酰胺、甲氨蝶呤、氟尿嘧啶治疗方案中，苯达莫司汀取代环磷酰胺，使转移性乳腺癌病人的缓解期从6.2个月延长至15.2个月。盐酸苯达莫司汀作为新一代抗癌药物，对多种癌症具有明显的治疗作用。临床应用表明，本品单独治疗或联合用药治疗非何杰金淋巴瘤、多发性骨髓瘤、CLL和乳腺癌等，疗效确切，明显降低复发率与死亡率，而且不良反应小，安全性好。 【适应症】2008年3月，FDA首先批准盐酸苯达莫司汀用于治疗慢性淋巴细胞性白血病（CLL）。同年10月，FDA又批准了该药的第2个适应证，即在利妥昔单抗（rituximab，美罗华）或含利妥昔单抗方案治疗过程中，或者治疗6个月内，病情仍然进展的惰性B细胞非霍奇金淋巴瘤（NHL）患者。 【药理及药代动力学】盐酸苯达莫司汀的确切作用机制尚不十分清楚，但已知该药是携带一个嘌呤样苯并咪唑环的氮芥衍生物，兼具烷化剂和嘌呤类似物（抗代谢药）的双重作用机制。盐酸苯达莫司汀能通过几种不同途径导致细胞死亡，而且对静止期和分裂期细胞均有效。盐酸苯达莫司汀血浆蛋白结合率为94%～96%，数据显示该药一般不会与其他高蛋白结合药物相互置换。盐酸苯达莫司汀平均稳态分布容积约为25L，其全血/血浆浓度比为0.84～0.86。盐酸苯达莫司汀主要通过水解反应进行代谢，同时形成细胞毒性较低的代谢产物。该药经CYP1A2代谢途径可产生M3和M4两种活性代谢产物，但两者血浆浓度只分别相当于母体化合物的1/10和1/100，因此，可以推测苯达莫司汀的细胞毒性作用主要来自于其本身，而非其代谢物。 【禁忌症】对盐酸苯达莫司汀及甘露醇过敏者禁用。 【药物相互作用】 与CYP1A2抑制剂（如氟伏沙明，环丙沙星等）合用时，有可能会升高苯达莫司汀血浓度，并使其代谢物M3和M4浓度降低；与CYP1A2诱导剂（如奥美拉唑，抽烟等）合用时，有可能会降低苯达莫司汀血浓度，并使其代谢物M3和M4浓度升高。 【不良反应】苯达莫司汀常见不良反应包括恶心、呕吐、腹泻、疲乏、虚弱、皮疹、搔痒、一些感染症状和体征（如持续咽喉疼痛、发热和寒战）、容易碰伤/出血以及口腔溃疡等；严重不良反应可能还有骨髓抑制、肿瘤溶解综合征等。苯达莫司汀可能引起轻微或严重过敏反应，患者在给药过程中或给药后初期可能出现皮疹、面部肿胀、呼吸困难等过敏症状。苯达莫司汀可能对胎儿造成影响，因此，女性治疗过程中及治疗后3个月内，应采取适当避孕措施及停止哺乳。 【剂量及用药】苯达莫司汀冻干粉针呈白色至灰白色，规格为100mg/支。该药储存温度不应超过30℃，避光保存，使用前临时配制。配制流程：该药每100mg须先溶于20ml无菌注射用水，充分振摇直到完全溶解成澄清、无色或淡黄色溶液，溶解时间一般不超过5分钟，溶解后浓度为5mg/ml。在溶解后30分钟之内，根据需要抽取适量苯达莫司汀水溶液，转移至500ml氯化钠注射液（0.9%）或葡萄糖氯化钠注射液（2.5%/0.45%）中，并确保苯达莫司汀在注射液中的最终浓度在0.2～0.6mg/ml之间。配制好的注射液可在2～8℃冷藏保存24小时，或在室温及自然光下保存3小时。苯达莫司汀治疗CLL时，以28天为一个治疗周期，一般需要6个治疗周期。在每个治疗周期的第一天和第二天给药，推荐剂量为100mg/m2。该药经静脉滴注给药，每次给药时间不应少于30分钟。苯达莫司汀治疗NHL时，以21天为一个治疗周期，一般需要8个治疗周期。在每个治疗周期的第一天和第二天给药，推荐剂量为120mg/m2。每次给药时间不应少于60分钟。 【患者咨询】用药前应告知主诊医生有关过敏史、详细的用药史及其他伴发疾病，特别是血液/骨髓病、肾脏病、肝病、感染疾病等，同时应与医生详细讨论服药的风险及受益情况，避免与其他可能产生不良相互作用的药物合用。该药可能使现有感染加重，因此，在未征得医生同意前，患者不要自行进行疫苗接种；同时应避免与近期口服过脊髓灰质炎疫苗或通过鼻吸入给予流感疫苗的人群，又或者是其他传染病（如水痘、流感）患者接触。

英文版说明书：

TreandaGeneric Name: bendamustineBrand Names: TreandaWhat is Treanda?Treanda (bendamustine) is a cancer medicine that interferes with the growth of cancer cells and slows their growth and spread in the body.Treanda is used to treat chronic lymphocytic leukemia. It is also used to treat indolent B-cell non-Hodgkin lymphoma after other medications have been tried without successful treatment of this condition.Treanda may also be used for purposes not listed in this medication guide.Important informationTreanda is used to treat chronic lymphocytic leukemia, or indolent B-cell non-Hodgkin lymphoma.Before you receive Treanda, tell your doctor if you have a weak immune system, fever or other signs of infection, a metabolic disorder or electrolyte imbalance, liver or kidney disease, or if you smoke.Tell your caregiver right away if you have a fever, chills, itching, or skin rash during or shortly after the injection.Treanda can lower blood cells that help your body fight infections and help your blood to clot. You may get an infection or bleed more easily. Call your doctor if you have unusual bruising or bleeding, or signs of infection (fever, chills, body aches).Before I receive TreandaYou should not receive Treanda if you are allergic to bendamustine or mannitol (Osmitrol).To make sure Treanda is safe for you, tell your doctor if you have:•a weak immune system;•fever or other signs of infection;•a metabolic disorder or electrolyte imbalance;•liver disease;•kidney disease; or•if you smoke.FDA pregnancy category D. Do not receive Treanda if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.See also: Pregnancy and breastfeeding warnings (in more detail)It is not known whether bendamustine passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.Some people receiving Treanda have developed certain types of cancers. It is not known whether this medication causes cancer. Talk with your doctor about the risks and benefits of using Treanda.How is Treanda given?Treanda is injected into a vein through an IV. A healthcare provider will give you this injection.Treanda is usually given for 2 days in a row every 21 to 28 days. You may receive up to 8 treatments total, depending on the condition being treated. Follow your doctor's instructions.You may be given other medications to help prevent certain side effects of Treanda.Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.Treanda can lower blood cells that help your body fight infections and help your blood to clot. Your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests.What happens if I miss a dose?Call your doctor for instructions if you miss an appointment for your Treanda injection.What happens if I overdose?Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.What should I avoid?Treanda may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.Bendamustine can pass into body fluids (including urine, feces, vomit, semen, vaginal fluid). For at least 48 hours after you receive a dose, avoid allowing your body fluids to come into contact with your hands or other surfaces. Patients and caregivers should wear rubber gloves while cleaning up body fluids, handling contaminated trash or laundry or changing diapers. Wash hands before and after removing gloves. Wash soiled clothing and linens separately from other laundry.Body fluids should not be handled by a woman who is pregnant or who may become pregnant. Use condoms during sexual activity to avoid exposure to body fluids.Treanda side effectsSome people receiving a Treanda injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you have fever, chills, itching, or skin rash during or shortly after the injection.Get emergency medical help if you have any of these signs of an allergic reaction to Treanda: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.Tell your caregivers at once if you have:•fever, chills, body aches, flu symptoms, sores in your mouth and throat;•pale skin, feeling light-headed or short of breath, rapid heart rate, trouble concentrating;•easy bruising or bleeding, purple or red pinpoint spots under your skin, unusual weakness;•cold symptoms such as stuffy nose, sneezing, cough, sore throat;•lower back pain, blood in your urine, urinating less than usual or not at all;•numbness or tingly feeling around your mouth;•muscle weakness, tightness, or contraction, overactive reflexes;•fast or slow heart rate, weak pulse, confusion;•dry mouth, feeling very thirsty or hot, heavy sweating or hot and dry skin;•severe blistering, peeling, and red skin rash; or•pain, swelling, redness, skin changes, or signs of infection where the medicine was injected.Common Treanda side effects may include:•mild nausea, vomiting, diarrhea, constipation, or upset stomach;•swelling in your hands or feet;•headache, dizziness, drowsiness;•loss of appetite, weight loss; or•mild skin rash.This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.See also: Side effects (in more detail)What other drugs will affect Treanda?Tell your doctor about all medicines you use, and those you start or stop using during your treatment with Treanda, especially:•allopurinol;•carbamazepine;•cimetidine;•ciprofloxacin;•fluvoxamine;•omeprazole;•thiabendazole; or•a barbiturate--butabarbital, secobarbital, phenobarbital, and others.This list is not complete. Other drugs may interact with Treanda, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.